Inflammatory Diseases and Vitamin E-What Do We Know and Where Do We Go?

Area of Science:

• Nutrition and Metabolism
• Immunology
• Biochemistry

Background:

• Inflammation-driven diseases, including metabolic syndrome, obesity, fatty liver disease (NAFLD), and cardiovascular diseases, represent a significant global health burden.
• Nutrients play a crucial role in modulating inflammatory responses, offering potential therapeutic strategies for these conditions.
• The inflammasome, particularly NLRP3 (nucleotide-binding domain and leucine-rich repeat pyrin domain 3), is a key mediator in inflammation and associated disorders.

Purpose of the Study:

• To provide an overview of cellular signaling pathways involved in NF-κB (nuclear factor "kappa-light-chain-enhancer" of activated B-cells) and NLRP3-mediated inflammation.
• To discuss the pathogenesis of atherosclerosis and NAFLD.
• To review current drug-based and dietary interventions for cardiovascular diseases and NAFLD, with a focus on Vitamin E.

Main Methods:

• Literature review of cellular signaling pathways in inflammation.
• Analysis of pathogenesis in atherosclerosis and NAFLD.
• Synthesis of current knowledge on therapeutic interventions, including dietary approaches like Vitamin E supplementation.

Main Results:

• NF-κB and NLRP3 inflammasome pathways are central to inflammatory processes underlying diseases like atherosclerosis and NAFLD.
• Vitamin E, a major dietary antioxidant, and its derivatives exhibit anti-inflammatory activities in various in vitro and in vivo studies.
• Emerging evidence suggests Vitamin E and its metabolites are a promising therapeutic approach for inflammatory conditions, including NAFLD.

Conclusions:

• Vitamin E and its metabolites demonstrate significant potential as therapeutic agents for inflammatory diseases, particularly NAFLD.
• Understanding the role of inflammasomes and nutrient-mediated modulation of inflammation is critical for developing effective treatments.
• Dietary interventions, especially those involving antioxidants like Vitamin E, warrant further investigation for managing chronic inflammatory conditions.